Skip to main content

and
  1. No Access

    Protocol

    Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus

    The advent of direct-acting antivirals (DAAs) has brought about a sudden renaissance in the treatment of chronic hepatitis C virus (HCV) infection with SVR rates now routinely >90%. However, due to the error-p...

    Darrick K. Li, Raymond T. Chung in Hepatitis C Virus Protocols (2019)